Low-Dose Interleukin-2 Ameliorates Colitis in a Preclinical Humanized Mouse Model.

ABSTRACT:

SUBMITTER: Goettel JA 

PROVIDER: S-EPMC6661391 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature